Welcome to our dedicated page for PACS Group SEC filings (Ticker: PACS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on PACS Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into PACS Group's regulatory disclosures and financial reporting.
PACS Group, Inc. reports that the NYSE Listing Operations Committee has granted the company an additional trading period through November 19, 2025 to regain compliance with NYSE rule 802.01E on timely filing of annual and quarterly reports, with the situation reassessed on an ongoing basis. The company has not yet filed its Form 10-Q for the quarter ended September 30, 2024, its Form 10-K for the year ended December 31, 2024, or its Forms 10-Q for the quarters ended March 31, 2025 and June 30, 2025, due to an independent Audit Committee investigation. PACS Group previously said that its condensed combined/consolidated financial statements for the quarters ended March 31, 2024 and June 30, 2024 should no longer be relied upon and is working to restate these statements and complete the delayed reports. The NYSE will monitor the company’s progress as it seeks to return to full listing compliance.
PACS Group, Inc. reported that Chief Financial Officer Derick Apt resigned on September 2, 2025 after the board’s Audit Committee, following allegations he accepted a series of high-value items from individuals linked to entities that do business with the company, made interim findings that his receipt of those items violated company policies and its Code of Conduct. In a separation agreement, Apt provided a broad release of claims and reaffirmed non-solicitation, non-disparagement and confidentiality covenants, while the company agreed to accelerate vesting of 82,116 restricted stock units, with his remaining unvested units forfeited, and waived a one-year non-competition covenant. The company has launched a search for a permanent CFO and bolstered its finance and accounting resources. On September 3, 2025, co-founder and current Executive Vice Chairman Mark Hancock, who previously served as CFO from 2013 to 2024, was appointed interim Chief Financial Officer and will act as principal financial officer while continuing as a director.
PACS Group, Inc. disclosed that Peter (P.J.) Sanford, President of Providence Administrative Consulting Services, Inc., resigned as an employee and executive officer of the company effective August 15, 2025. The parties negotiated a separation agreement under which Mr. Sanford will execute a general release of claims and reaffirm his continuing obligations under certain restrictive covenants. The company agreed to subsidize 12 months of Mr. Sanford's COBRA premiums. The company will also enter a consulting agreement to keep Mr. Sanford available to provide services. The filing states the full separation and consulting agreements will be filed as exhibits to the company's next quarterly report.
PACS Group, Inc. filed a Form 12b-25 notifying the SEC of a late Form 10-Q for the quarter ended June 30, 2024. The company states the delay is due to an ongoing investigation and that management is working to complete that review before filing. The notice contains standard forward-looking language that outcomes and timing may change and refers investors to the company’s disclosed Risk Factors.